Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer

Lung Cancer

Volumn 49, Issue 1, 2005, Pages 85-94

  Imaizumi, Munehisa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant chemotherapy; Five year survival; Non small cell lung cancer; Randomized controlled trial; Stage I; UFT

Indexed keywords

CISPLATIN; TEGAFUR; URACIL; VINDESINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TEGAFUR; VINDESINE;

EID: 20444375510     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.11.025     Document Type: Article

References (29)

1. M.J. Mathews, S. Kanhouwa, J. Pickren, and D. Robinette Frequency of residual and metastatic tumor in patients undergoing curative resection for lung cancer Cancer Chemother Rep 4 1973 63 67
2. R. Feld, L.V. Rubinstein, T.H. Weisenberger the Lung Cancer Study Group Site of recurrence stage I non-small cell lung cancer, a guide for future studies J Clin Oncol 2 1984 1352 1358
3. C.F. Mountain A new international staging system for lung cancer Chest 89 Suppl 1986 225S 233S
4. H. Wada, S. Hitomi, T. Teramatsu West Japan Study Group for Lung Cancer Surgery Adjuvant chemotherapy after complete resection in non-small cell lung cancer J Clin Oncol 14 1996 1048 1054
5. The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan). A randomized trial of postoperative adjuvant in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol 1995;21:59-77.
6. A. Niiranen, S. Niitamo-Korhonen, M. Kouri, A. Assendelft, K. Mattson, and S. Pyrhönen Adjuvant chemotherapy of the radical surgery for non-small cell lung cancer: a randomized study J Clin Oncol 10 1992 1927 1932
7. R. Feld, L. Rubinstein, P.A. Thomas Lung Cancer Study Group Adjuvant chemotherapy cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer J Natl Cancer Inst 85 1993 299 306
8. H. Wada, R. Miyahara, F. Tanaka, S. Hitomi West Japan Study Group Postoperative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin C) and UFT (uracil + tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial Eur J Cardiothorac Surg 15 1999 438 443
9. A.B. Miller, B. Hoogstraten, M. Staquest, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214
10. J.M. Lachin, and M.A. Foulkes Evaluation of sample size and power for analysis of survival with allowance for non uniform patient entry, losses to follow-up, noncompliance, and stratification Biometrics 42 1986 507 519
11. SUGI supplemented Library User's Guide, version 5 ed., SAS Inc. 1986.
12. D.R. Cox Regression model and life table J R Stat Soc 23 1972 187 220
13. E.W. Humphre, C.R. Smart, D.P. Winchester, G.D. Steele, J.W. Yarbro, and K.C. Chu National survey of the patient of case for carcinoma of the lung J Thorac Cardiovasc Surg 100 1990 837 843
14. M.S. Bains Surgical treatment of lung cancer Chest 100 1991 826 837
15. W.J. Mackillop, B. O'Sullivan, and G.K. Ward Non-small cell lung cancer: how oncologists want to be treated Int J Radiat Oncol Biol Phys 13 1987 929 934
16. A. Motohiro, N. Hirota, H. Komatsu, N. Yanai National chest Hospital Study Group for Lung Cancer Japanese doctors' preferred treatment choice for their hypothetical non-small lung cancer. How they would wish to be treated Lung Cancer 11 1994 43 50
17. A. Ohgumi, T. Mitsudomi, K. Sugio, T. Tsuda, T. Oyama, and K. Nishida Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer Ann Thorac Surg 64 1997 363 367
18. P.A. Ganz, R.A. Figlin, C.M. Haskell, N.L. Soto, and J. Siau Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer: does chemotherapy make a difference? Cancer 63 1989 1271 1278
19. R. Cellerino, D. Tumarello, F. Guidi, P. Isidori, M. Raspugli, and B. Biscottini A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small lung cancer J Clin Oncol 9 1991 1453 1461
20. R.J. Gralla, E.S. Casper, D.P. Kelsen, D.W. Braun, M.E. Dukeman, and C.W. Young Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules Ann Intern Med 95 1981 414 420
21. E. Rapp, J.L. Pater, A. Willan, Y. Cormier, N. Murray, and W.K. Evans Chemotherapy can prolong survival in patient with advanced non-small lung cancer. Report of a Canadian multicenter randomized trial J Clin Oncol 6 1998 633 641
22. H. Kato, Y. Ichinose, M. Ohta, E. Hata, N. Tsubota, H. Tada for the Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
23. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004;350:351-60.
24. 0 non-small cell lung cancer J Thorac Cardiovasc Surg 106 1993 1053 1058
25. N. Martini, M.S. Bains, M.E. Burt, M.F. Zakowski, P. McCormack, and V.W. Rusch Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
26. A non-small cell lung cancer J Thorac Cardiovasc Surg 117 1999 32 38
27. T. Kikuchi, Y. Daigo, T. Kanagiri, T. Tsunoda, K. Okada, and S. Kakiuchi Expression profiles of non-small cell lung cancers on cDNA microassays. Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs Oncogene 22 2003 2192 2205
28. K. Yanagisawa, Y. Shyr, B.J. Xu, P.P. Massion, P.H. Larsen, and B.C. White Proteomic patterns of tumor subsets in non-small cell lung cancer Lancet 362 2003 433 439
29. M.J. Friedrich Genomics and proteomics may help clinicians individualize cancer treatment. JAMA 287 2002 293